bf/NASDAQ:OCUL_icon.jpeg

COM:OCUTX

Ocular Therapeutix

  • Stock

Last Close

8.56

30/08 20:00

Market Cap

1.11B

Beta: -

Volume Today

597.69K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
772K
-
1.75M
126.68%
1.89M
7.83%
1.92M
1.91%
1.99M
3.48%
4.23M
112.41%
17.40M
311.71%
43.52M
150.08%
51.49M
18.32%
58.44M
13.49%
cost of revenue
91K
-
319K
250.55%
443K
38.87%
457K
3.16%
465K
1.75%
2.33M
400%
2.08M
10.41%
4.41M
111.52%
4.54M
3.04%
5.28M
16.32%
gross profit
681K
-
1.43M
110.13%
1.44M
0.91%
1.47M
1.52%
1.52M
4.02%
1.90M
24.72%
15.32M
705.47%
39.12M
155.33%
46.95M
20.04%
53.16M
13.22%
selling and marketing expenses
625K
-
1.98M
217.12%
3.85M
94.35%
6.70M
73.96%
17M
153.69%
4.94M
70.93%
24.49M
395.57%
26.61M
8.67%
35.19M
32.22%
39.92M
13.45%
4.83M
87.91%
general and administrative expenses
1.76M
-
6.91M
292.56%
9.16M
32.58%
11.00M
20.07%
15.51M
40.94%
18.79M
21.13%
22.12M
17.76%
22.86M
3.33%
31.88M
39.46%
32.22M
1.08%
69.66M
116.18%
selling general and administrative expenses
2.39M
-
8.89M
272.80%
13.02M
46.34%
17.70M
36.01%
32.51M
83.61%
23.73M
27.01%
46.61M
96.45%
49.47M
6.14%
67.07M
35.57%
72.15M
7.57%
74.49M
3.25%
research and development expenses
10.52M
-
18.88M
79.52%
26.61M
40.95%
27.07M
1.71%
30.88M
14.10%
36.91M
19.54%
41.09M
11.31%
28.69M
30.17%
50.08M
74.54%
53.46M
6.75%
61.05M
14.20%
other expenses
14K
-
-442K
3,257.14%
7K
101.58%
-1K
114.29%
5K
600%
-8K
-
1K
-
-1K
200%
-1K
0%
cost and expenses
12.90M
-
27.87M
115.97%
39.95M
43.35%
45.21M
13.18%
63.85M
41.21%
61.11M
4.29%
90.03M
47.33%
80.25M
10.86%
121.56M
51.48%
130.15M
7.07%
140.82M
8.20%
operating expenses
12.90M
-
27.77M
115.26%
39.63M
42.68%
44.77M
12.98%
63.39M
41.59%
60.64M
4.33%
87.70M
44.62%
78.17M
10.87%
117.15M
49.88%
125.61M
7.22%
135.54M
7.91%
interest expense
441K
-
1.12M
153.74%
1.72M
54.07%
1.68M
2.55%
1.89M
12.62%
1.74M
8.09%
6.10M
250.83%
6.77M
10.93%
6.67M
1.43%
7.02M
5.26%
11.34M
61.46%
ebitda
-12.47M
-
-27.53M
120.73%
-38.02M
38.12%
-43.02M
13.15%
-61.49M
42.93%
-58.24M
5.29%
-84.58M
45.23%
-62.68M
25.89%
-78.00M
24.45%
-77.86M
0.19%
-79.40M
1.98%
operating income
-12.90M
-
-27.09M
109.98%
-38.20M
40.98%
-43.33M
13.43%
-61.92M
42.92%
-59.12M
4.53%
-85.80M
45.14%
-62.85M
26.75%
-78.04M
24.17%
-78.65M
0.79%
-82.38M
4.74%
depreciation and amortization
404K
-
547K
35.40%
754K
37.84%
881K
16.84%
1.63M
84.45%
879K
45.91%
1.22M
38.91%
168K
86.24%
34K
79.76%
797K
2,244.12%
2.98M
274.28%
total other income expenses net
14K
-
-442K
3,257.14%
7K
101.58%
-1K
114.29%
5K
600%
-860K
17,300%
-570K
33.72%
-92.79M
16,178.77%
71.48M
177.04%
7.62M
89.35%
1.65M
78.39%
income before tax
-13.32M
-
-28.65M
115.12%
-39.75M
38.75%
-44.70M
12.47%
-63.39M
41.79%
-59.98M
5.38%
-86.37M
44.01%
-155.64M
80.19%
-6.55M
95.79%
-71.04M
984.05%
-80.74M
13.65%
income tax expense
455K
-
130K
71.43%
977K
651.54%
798K
18.32%
272K
65.91%
-2.29M
940.44%
3.56M
255.86%
4.00M
12.12%
4.25M
6.41%
-7.62M
279.16%
net income
-13.32M
-
-28.65M
115.12%
-39.75M
38.75%
-44.70M
12.47%
-63.39M
41.79%
-57.69M
8.98%
-89.94M
55.89%
-159.63M
77.50%
-10.80M
93.23%
-63.42M
487.02%
-80.74M
27.30%
weighted average shs out
2.95M
-
10.65M
260.79%
23.24M
118.20%
24.82M
6.76%
28.82M
16.13%
38.12M
32.26%
45.27M
18.78%
60.75M
34.19%
76.39M
25.74%
76.88M
0.63%
79.83M
3.84%
weighted average shs out dil
2.95M
-
10.65M
260.79%
23.24M
118.20%
24.82M
6.76%
28.82M
16.13%
38.12M
32.26%
45.27M
18.78%
60.75M
34.19%
82.16M
35.24%
76.88M
6.43%
85.60M
11.35%
eps
-4.51
-
-2.69
40.35%
-1.71
36.43%
-1.80
5.26%
-2.20
22.22%
-1.51
31.36%
-1.99
31.79%
-2.63
32.16%
-0.14
94.68%
-0.83
492.86%
-1.01
21.69%
epsdiluted
-4.51
-
-2.69
40.35%
-1.71
36.43%
-1.80
5.26%
-2.20
22.22%
-1.51
31.36%
-1.99
31.79%
-2.63
32.16%
-0.13
95.06%
-0.83
538.46%
-0.94
13.25%

All numbers in (except ratios and percentages)